Explore breakthrough studies on synaptic transmission, receptor mechanisms, and neurological disorder pathways
Discover how Aβ−3–40, a novel cerebrospinal fluid biomarker, is revolutionizing early Alzheimer's disease detection through advanced biochemical analysis.